Wedbush Reaffirms Neutral Rating for Alto Neuroscience (NYSE:ANRO)
Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “neutral” rating reiterated by Wedbush in a report issued on Thursday,Benzinga reports. They presently have a $4.00 target price on the stock. Wedbush’s price target would suggest a potential upside of 56.80% from the stock’s current price. Wedbush also issued estimates for Alto Neuroscience’s Q1 […]
Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “neutral” rating reiterated by Wedbush in a report issued on Thursday,Benzinga reports. They presently have a $4.00 target price on the stock. Wedbush’s price target would suggest a potential upside of 56.80% from the stock’s current price. Wedbush also issued estimates for Alto Neuroscience’s Q1 […]
